Altamira Therapeutics's market cap is currently $514.39K. The company's EPS TTM is $-0.306; its P/E ratio is ―; Altamira Therapeutics is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23
Dec 22
Dec 21
Dec 20
Dec 19
Currency in CHF
Altamira Therapeutics Earnings and Revenue History
